Conversion from sandimmune to neoral in renal transplant recipients: two-year experience

By Wilczek H.E.   &   9kesson P.   Warholm C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1753-1755

Elsevier

Access to resources Recommend Favorite

Cyclosporine neoral profiling in japanese renal transplant recipients

By Aikawa A.   Arai K.   Tajima E.   Kawamura T.   Ogiwara H.   Sakai K.   Mizuiri S.   Ohara T.   Hasegawa A.   Kosugi T.   Kusano A.   Matsuo K.   Obayashi M.   Kurokawa M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3142-3145

Elsevier

Access to resources Recommend Favorite

Effect of Conversion From Sandimmune to Neoral on Glomerular Filtration Rate in Stable Renal Transplant Recipients

By Steinmuller D.   Dougherty J.   Coutee J.   Surek D.   Swies G.   Lewis R.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 298-299

Elsevier

Access to resources Recommend Favorite

Conversion to sandimmun neoral in stable renal transplant recipients over 1 year: hepatitis, liver dysfunction, dosing intervals, and therapeutic ranges

By Hsieh H.   Chien Y.S.   Hsu K.T.   Chung H.M.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3552-3554

Elsevier

Access to resources Recommend Favorite

Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method

By First M.R.   Weiskittel P.   Shah M.   Peddi V.R.   Canafax D.   Schroeder T.J.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 3955-3957

Elsevier

Access to resources Recommend Favorite